MENTRIK Biotech is clinical stage company, developing monoclonal antibodies for the treatment of cancer and autoimmune diseases.

Mentrik Biotech, LLC
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.mentrik.com
Founded2010
Disease Focus
Development StageClinical
STOCK CODENon Listed
Address5420 LBJ Freeway Suite 410,Texas,75240DallasUnited States
5420 LBJ Freeway Suite 410,Texas,75240
Dallas
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/mentrik-biotech” connections=”true” suffix=””]
In Jan 2011, MENTRIK Biotech, acquires Fc Engineered, High Affinity, Fully Humanized Anti-CD20 Antibody (AME133) from Eli Lilly and Company.